AVITA Medical (RCEL) Revenue & Revenue Breakdown
AVITA Medical Revenue Highlights
Latest Revenue (Y)
$50.56M
Latest Revenue (Q)
$18.42M
Main Segment (Y)
Lease Revenue
Main Geography (Y)
UNITED STATES
AVITA Medical Revenue by Period
AVITA Medical Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2022-12-31 | $50.56M | 254.49% |
| 2021-06-30 | $14.26M | -30.99% |
| 2020-06-30 | $20.67M | 2246.74% |
| 2018-06-30 | $880.67K | -25.41% |
| 2017-06-30 | $1.18M | 17.83% |
| 2016-06-30 | $1.00M | 1.66% |
| 2015-06-30 | $985.65K | -63.27% |
| 2014-06-30 | $2.68M | -4.68% |
| 2013-06-30 | $2.81M | -16.03% |
| 2012-06-30 | $3.35M | 0.50% |
| 2011-06-30 | $3.34M | 45.24% |
| 2010-06-30 | $2.30M | -2.97% |
| 2009-06-30 | $2.37M | 96.64% |
| 2008-06-30 | $1.20M | 52.17% |
| 2007-06-30 | $790.99K | -10.46% |
| 2006-06-30 | $883.39K | 127.05% |
| 2004-06-30 | $389.08K | 100.23% |
| 2002-12-31 | $194.32K | 100.00% |
| 2001-12-31 | - | 100.00% |
| 2000-12-31 | - | 100.00% |
| 1999-12-31 | - | -100.00% |
| 1998-12-31 | $582.97K | 100.00% |
| 1997-12-31 | - | 100.00% |
| 1996-12-31 | - | 100.00% |
| 1995-12-31 | - | 100.00% |
| 1994-12-31 | - | 100.00% |
| 1993-12-31 | - | - |
AVITA Medical generated $50.56M in revenue during NA 2022, up 254.49% compared to the previous quarter, and up 5045.97% compared to the same period a year ago.
AVITA Medical Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-06-30 | $18.42M | -0.52% |
| 2025-03-31 | $18.51M | 0.59% |
| 2024-12-31 | $18.41M | -5.83% |
| 2024-09-30 | $19.55M | 28.63% |
| 2024-06-30 | $15.20M | 36.84% |
| 2024-03-31 | $11.10M | -21.78% |
| 2023-12-31 | $14.20M | 4.03% |
| 2023-09-30 | $13.64M | 16.10% |
| 2023-06-30 | $11.75M | 11.40% |
| 2023-03-31 | $10.55M | 11.58% |
| 2022-12-31 | $9.46M | 3.99% |
| 2022-09-30 | $9.09M | 9.08% |
| 2022-06-30 | $8.34M | 10.56% |
| 2022-03-31 | $7.54M | 100.00% |
| 2021-12-31 | - | -100.00% |
| 2021-09-30 | $7.02M | -31.87% |
| 2021-06-30 | $10.30M | 17.56% |
| 2021-03-31 | $8.77M | 71.76% |
| 2020-12-31 | $5.10M | 0.85% |
| 2020-09-30 | $5.06M | 30.51% |
| 2020-06-30 | $3.88M | - |
| 2020-03-31 | $3.88M | 18.96% |
| 2019-12-31 | $3.26M | -32.32% |
| 2019-09-30 | $4.82M | 130.02% |
| 2019-06-30 | $2.09M | - |
| 2019-03-31 | $2.09M | 227.82% |
| 2018-12-31 | $638.58K | -2.54% |
| 2018-09-30 | $655.25K | 151.18% |
| 2018-06-30 | $260.87K | 14.90% |
| 2018-03-31 | $227.05K | -4.25% |
| 2017-12-31 | $237.13K | -0.50% |
| 2017-09-30 | $238.32K | - |
AVITA Medical generated $18.42M in revenue during Q2 2025, up -0.52% compared to the previous quarter, and up 165.87% compared to the same period a year ago.
AVITA Medical Revenue Breakdown
AVITA Medical Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 24 | Dec 22 | Jun 21 | Jun 20 |
|---|---|---|---|---|
| Lease Revenue | $358.00K | - | - | - |
| Foreign | - | $160.00K | $171.00K | - |
| Recell System | - | - | $435.00K | - |
AVITA Medical's latest annual revenue breakdown by segment (product or service), as of Dec 24: Lease Revenue (100.00%).
Quarterly Revenue by Product
| Product/Service | Jun 25 | Mar 25 | Dec 24 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Recell System | $16.82M | $17.68M | $399.00K | $408.00K | $416.00K | $432.00K | $435.00K | $435.00K | $435.00K | $4.10M | - | - | - | - | - |
| Lease Revenue | $192.00K | $189.00K | $194.00K | - | - | - | - | - | - | - | - | - | - | - | - |
| Foreign | - | - | - | - | - | - | $39.00K | $15.00K | $30.00K | $10.00K | - | - | - | - | - |
AVITA Medical's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: Recell System (98.87%), and Lease Revenue (1.13%).
AVITA Medical Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 24 | Dec 22 | Jun 21 | Jun 20 |
|---|---|---|---|---|
| UNITED STATES | $62.16M | $33.26M | $28.95M | $13.80M |
| AUSTRALIA | $312.00K | - | - | - |
| European Union | $155.00K | - | - | - |
| JAPAN | $1.43M | - | - | - |
AVITA Medical's latest annual revenue breakdown by geography, as of Dec 24: UNITED STATES (97.04%), JAPAN (2.23%), AUSTRALIA (0.49%), and European Union (0.24%).
Quarterly Revenue by Country
| Country | Jun 25 | Mar 25 | Dec 24 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JAPAN | $427.00K | $634.00K | $193.00K | $581.00K | $708.00K | $1.02M | - | - | - | - | - | - | - | - | - |
| European Union | $49.00K | $49.00K | $1.00K | - | - | - | - | - | - | - | - | - | - | - | - |
| UNITED STATES | $17.90M | $17.76M | $18.00M | $12.96M | $10.99M | $9.43M | $8.59M | $9.00M | $8.28M | $7.40M | $10.24M | $8.72M | $5.02M | $4.97M | - |
| AUSTRALIA | $40.00K | $40.00K | $180.00K | $61.00K | $33.00K | $62.00K | - | - | - | - | - | - | - | - | - |
| U S | - | - | - | - | - | - | - | - | - | - | $6.92M | - | - | - | - |
AVITA Medical's latest quarterly revenue breakdown by geography, as of Jun 25: UNITED STATES (97.20%), JAPAN (2.32%), European Union (0.27%), and AUSTRALIA (0.22%).
AVITA Medical Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| LUCD | Lucid Diagnostics | $4.35B | $1.21B |
| QIPT | Quipt Home Medical | $245.91M | $58.29M |
| FONR | FONAR | $104.35M | $2.02M |
| RCEL | AVITA Medical | $50.56M | $18.42M |
| APYX | Apyx Medical | $48.10M | $12.88M |
| HYPR | Hyperfine | $12.89M | $2.70M |
| NSPR | InspireMD | $7.01M | $2.52M |
| STTK | Shattuck Labs | $5.72M | - |
| OVID | Ovid Therapeutics | $566.00K | $132.00K |
| VANI | Vivani Medical | - | - |